Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

Conditions:   Methamphetamine Abuse;   Methamphetamine-dependence;   Addiction, Substance;   Addiction Interventions:   Drug: Treatment as Usual plus Placebo;   Drug: Treatment as Usual plus Placebo plus Contingency Management;   Drug: Treatment as Usual plus lisdexamfetamine (LDX-01);   Drug: Treatment as Usual plus lisdexamfetamine (LDX-01) plus Contingency Management Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Canadian Institutes of Health Research (CIHR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials